Clear All
12159 Matching Results — Export these results
Click column titles once to sort ascending, and twice to sort descending.
NDC-11 (Package) NDC-9 (Product) Generic Name Brand Name Strength SEER*Rx Category Major Class Minor Class Administration Route Package Effective Date Package Discontinuation Date Status
73207-0302-40 73207-0302 Vimseltinib ROMVIMZA 14.0 mg/1 Chemotherapy Tyrosine Kinase Inhibitor CSF1R Oral Feb 14, 2025 In Use
40051-0604-53 40051-0604 Temozolomide Temozolomide 5.0 mg/1 Chemotherapy Alkylating Agent Tetrazine Oral Aug 1, 2016 In Use
72237-0101-03 72237-0101 Selinexor XPOVIO 20.0 mg/1 Chemotherapy Enzyme Inhibitor XPO1 Oral Jun 22, 2020 In Use
55150-0376-01 55150-0376 Decitabine Decitabine 50.0 mg/26mL Chemotherapy Antimetabolite Pyrimidine Analog Intravenous Sep 20, 2021 In Use
67253-0320-36 67253-0320 METHOTREXATE Methotrexate 2.5 mg/1 Chemotherapy Antimetabolite Folic Acid Analog Oral Dec 7, 1953 Feb 28, 2021 No Longer Used
00008-0045-02 00008-0045 Vinorelbine tartrate Vinorelbine tartrate 10.0 mg/mL Chemotherapy Antimitotic Agent Vinca Alkaloid Intravenous Feb 13, 2008 In Use
16729-0248-38 16729-0248 Mitomycin Mitomycin 40.0 mg/10mL Chemotherapy Antitumor Antibiotic Alkylating Agent/ Mitomycin Intravenous May 3, 2013 Jan 31, 2023 No Longer Used
39822-0255-01 39822-0255 Cyclophosphamide CYCLOPHOSPHAMIDE 1.0 g/50mL Chemotherapy Alkylating Agent Nitrogen Mustard Intravenous, Oral Dec 19, 2023 In Use
46708-0620-05 46708-0620 Paclitaxel Paclitaxel 6.0 mg/mL Chemotherapy Antimitotic Agent Taxane Intravenous Oct 20, 2022 In Use
68382-0245-16 68382-0245 Imatinib mesylate Imatinib mesylate 400.0 mg/1 Chemotherapy Tyrosine Kinase Inhibitor BCR-ABL Oral Jan 21, 2021 In Use
00409-7870-01 00409-7870 DOCETAXEL ANHYDROUS Docetaxel 10.0 mg/mL Chemotherapy Antimitotic Agent Taxane Intravenous Jun 28, 2021 In Use
62756-0239-20 62756-0239 Capecitabine Capecitabine 500.0 mg/1 Chemotherapy Antimetabolite Pyrimidine Analog Oral Sep 1, 2019 In Use
00143-9517-01 00143-9517 Methotrexate Methotrexate 25.0 mg/mL Chemotherapy Antimetabolite Folic Acid Analog Intra-Arterial, Intramuscular, Intrathecal, Intravenous Jan 5, 2018 In Use
67457-0449-17 67457-0449 Paclitaxel Paclitaxel 100.0 mg/16.7mL Chemotherapy Antimitotic Agent Taxane Intravenous Aug 7, 2014 Oct 31, 2020 No Longer Used
00019-9451-03 00019-9451 Sodium Iodide I-131 Sodium Iodide I-131 25.0 mCi/mL Chemotherapy Radiopharmaceutical Iodine 131 Oral Aug 22, 2011 Jul 1, 2017 No Longer Used
70860-0203-50 70860-0203 Pemetrexed disodium Pemetrexed 500.0 mg/20mL Chemotherapy Antimetabolite Folic Acid Analog Intravenous May 25, 2022 Apr 30, 2024 No Longer Used
70860-0200-50 70860-0200 Paclitaxel Paclitaxel 6.0 mg/mL Chemotherapy Antimitotic Agent Taxane Intravenous Mar 24, 2017 Dec 31, 2024 No Longer Used
62175-0245-19 62175-0245 Temozolomide Temozolomide 250.0 mg/1 Chemotherapy Alkylating Agent Tetrazine Oral Feb 10, 2016 In Use
70518-1398-00 70518-1398 Methotrexate Methotrexate 2.5 mg/1 Chemotherapy Antimetabolite Folic Acid Analog Oral Sep 4, 2018 In Use
00069-0174-01 00069-0174 Fluorouracil Fluorouracil 50.0 mg/mL Chemotherapy Antimetabolite Pyrimidine Analog Intravenous Jul 18, 2012 Nov 30, 2014 No Longer Used
16729-0072-12 16729-0072 Capecitabine Capecitabine 150.0 mg/1 Chemotherapy Antimetabolite Pyrimidine Analog Oral Jun 9, 2015 In Use
55111-0496-60 55111-0496 capecitabine capecitabine 150.0 mg/1 Chemotherapy Antimetabolite Pyrimidine Analog Oral Dec 10, 2020 In Use
72338-0100-01 72338-0100 Pemetrexed disodium Pemetrexed 100.0 mg/4mL Chemotherapy Antimetabolite Folic Acid Analog Intravenous Jun 4, 2018 In Use
64144-0504-02 64144-0504 Temozolomide Temozolomide 140.0 mg/1 Chemotherapy Alkylating Agent Tetrazine Oral Apr 13, 2016 In Use
67253-0320-10 67253-0320 METHOTREXATE Methotrexate 2.5 mg/1 Chemotherapy Antimetabolite Folic Acid Analog Oral Dec 7, 1953 Feb 28, 2021 No Longer Used

Found 12159 results — Export these results